Actoplus Met
Actoplus Met

2.02
A generic medicine indicated for diabetes. Lowers blood glucose levels by increasing insulin sensitivity and reducing glucose production in the liver.


Availability
In Stock
Delivery Time
Airmail (14-21 days) | Trackable (5-9 days)
Shipped in a discreet, unmarked envelope with all required documents enclosed.

Product Sheet

Active Ingredient(s)
Metformin, Pioglitazone
Reference Brand
Metformin, pioglitazone
Product Origin
Generic Alternative
Reference Manufacturer
Takeda Pharmaceuticals
Product Form
Tablet
Regulatory Classification
Prescription Only Medicine
Primary Category
Antidiabetics
Product Category
Thiazolidinedione, Biguanide Combination
Pharmacological Class
Antidiabetic Combination
Clinical Indications
Manufacturer Description
Designed to support glycemic control to manage blood glucose levels and address insulin resistance.
Mechanism of Action
Combines metformin to decrease hepatic glucose production with pioglitazone to improve peripheral insulin sensitivity.
Route of Administration
Oral
Onset Time
1–2 weeks
Duration
12–24 hours
Contraindications
Severe renal impairment, Congestive heart failure, Acute metabolic acidosis
Severe Adverse Events
Lactic acidosis — requires immediate medical attention, Congestive heart failure exacerbation — requires immediate medical attention
Common Side Effects
Nausea, Diarrhea, Headache
Uncommon Side Effects
Weight gain, Edema, Hypoglycemia
Drug Interactions
Contrast Media, Alcohol, Gemfibrozil
Pregnancy Safety Warnings
TGA Category C: Risk of adverse effects. Avoid during pregnancy. Breastfeeding: Avoid.
Age Restrictions
Approved for adults.
Storage Guidelines
Store below 25°C.
Related Products
Information related to Actoplus Met is compiled and periodically reviewed with reference to established medical sources and prescribing guidance. Content is provided for general reference and should be confirmed with a registered healthcare professional before use.
Categories
how to buy Addiction Recovery AU - Zyban Australia